Year 2020 / Volume 112 / Number 3
Editorial
Should we administer rectal anti-inflammatory drugs in all ERCPs in order to prevent pancreatitis? At least, it does not harm!

167-169

DOI: 10.17235/reed.2020.6871/2020

Jesús García-Cano, Miriam Viñuelas Chicano,

Abstract
Acute pancreatitis is the most common complication of endoscopic retrograde cholangio-pancreatography (ERCP). The sensitivity of the pancreas, which may respond with such violence to the slightest pressure exerted at the entrance to its main duct in the papilla of Vater, is even philosophically surprising. In fact, each touch on the papilla increases the potential for pancreatitis development. The initial stimulus resulting in obstruction of pancreatic secretion may be the edema caused by the catheter's physical contact, the thermal effect of sphincterotomy, or the overdistension induced by the injected contrast. The triggering fact is followed by a release of inflammatory cytokines, which induce changes in pancreatic microcirculation.
Share Button
New comment
Comments

05/03/2020 20:28:32
Buen temario


References
1.El Nakeeb A, El Hanafy E, Salah T, et al. Post-endoscopic retrograde
cholangiopancreatography pancreatitis: Risk factors and predictors of severity. World J Gastrointest Endosc 2016; 8:709-715.
2.Haraldsson E, Kylänpää L, Grönroos J, et al. Macroscopic appearance of the major duodenal papilla influences bile duct cannulation: a prospective multicenter study by the Scandinavian Association for Digestive Endoscopy Study Group for ERCP. Gastrointest Endosc 2019;90:957-963. doi:10.1016/j.gie.2019.07.014.
3.García-Cano J, Viñuelas Chicano M, Del Moral Martínez M, et al. Pancreatic stent insertion after an unintentional guidewire cannulation of the pancreatic duct during ERCP. Rev Esp Enferm Dig 2018;110:416-420. doi:10.17235/reed.2018.5230/2017.
4. Wu D, Wan J, Xia L, et al. The efficiency of aggressive hydration with lactated Ringer solution for the prevention of Post-ERCP pancreatitis: A Systematic Review and Meta-analysis. J Clin Gastroenterol 2017;51:e68-e76. doi: 10.1097/MCG.0000000000000856.
5.Patai Á, Solymosi N, Mohácsi L, Patai ÁV. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc. 2017;85:1144-1156.e1. doi: 10.1016/j.gie.2017.01.033.
6.Lindo Ricce M, Rodríguez López-Salazar T, Mendoza Jiménez-Ridruejo J, et al. Effectiveness of rectal indomethacin in the prevention of acute pancreatitis after endoscopic retrograde cholangiopancreatography in unselected patients. Rev Esp Enferm Dig 2020;
7.Del Olmo Martínez L, Velayos Jiménez B, Almaraz Gómez A. Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients. Rev Esp Enferm Dig. 2018: 110: 505-509. doi:10.17235/reed.2018.5259/2017.
8.Levenick JM, Gordon SR, Fadden LL, et al. Rectal indomethacin does not prevent Post-ERCP pancreatitis in consecutive patients. Gastroenterology 2016; 150: 911-7.
doi: 10.1053/j.gastro.2015.12.040.
9.Patai Á, Solymosi N, Patai ÁV. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation. J Clin Gastroenterol 2015;49:429-37. doi: 10.1097/MCG.0000000000000168.
10.Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2019 Dec 20. doi: 10.1055/a-1075-4080. [Epub ahead of print].
11. Yaghoobi M, Alzahrani MA, McNabb-Baltar J, et al. Rectal indomethacin prevents moderate to severe post-ERCP pancreatitis and death and should be used before the procedure: A meta-analysis of aggregate subgroup data. J Can Assoc Gastroenterol 2018;1:67-75. doi: 10.1093/jcag/gwy006.
12. García-Cano J, Reyes Guevara AK, Martínez Pérez T, L. et al. Prevention of post-ERCP acute pancreatitis with intravenous diclofenac administered after the endoscopic intervention [Spanish]. Rev Esp Enferm Dig 2013; 105 (Supl. I): 106
Citation tools
García-Cano J, Viñuelas Chicano M. Should we administer rectal anti-inflammatory drugs in all ERCPs in order to prevent pancreatitis? At least, it does not harm!. 6871/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 442 visits.
This article has been downloaded 281 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 10/01/2020

Accepted: 10/01/2020

Online First: 27/01/2020

Published: 05/03/2020

Article Online First time: 17 days

Article editing time: 55 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology